Inotuzumab ozogamicin and Recombinate recombinant
Determining the interaction of Inotuzumab ozogamicin and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin-Recombivax
- Inotuzumab ozogamicin-Recombivax HB
- Inotuzumab ozogamicin-Recombivax HB Adult
- Inotuzumab ozogamicin-Recombivax HB Dialysis Formulation
- Inotuzumab ozogamicin-Recombivax HB Pediatric/Adolescent
- Inotuzumab ozogamicin-Recort Plus
- Recombinate recombinant-Inotuzumab ozogamicin Intravenous
- Recombinate recombinant-Inova
- Recombinate recombinant-Inova 4/1 topical
- Recombinate recombinant-Inova 8/2 topical
- Recombinate recombinant-Inova ACT
- Recombinate recombinant-Inrebic